Add BrightSurf on Google Email

Combination treatment for methamphetamine use disorder shows promise in NIH study

A combination of injectable naltrexone and oral bupropion was found to be effective in treating adults with moderate or severe methamphetamine use disorder. Participants responded at a significantly higher rate to the treatment, with an NNT of 9, indicating its potential as a promising addition to current approaches.

SourceNIH/National Institute on Drug Abuse·JournalNew England Journal of Medicine·DateJan 13, 2021

A community-level intervention reduces alcohol-related crashes

A community-level alcohol intervention in California resulted in a significant reduction of alcohol-involved crashes among drivers aged 15-30. The study found that the intervention, which included sobriety checkpoints and saturation patrols, translated into approximately 310 fewer crashes across the intervention cities.

SourcePacific Institute for Research and Evaluation·JournalAmerican Journal of Preventive Medicine·DateDec 20, 2020

Pharma aims to make a better CBD

Researchers are developing CBD-based treatments for chronic inflammatory diseases, such as lupus and multiple sclerosis. Pharmaceutical companies are also working to enhance the potency of CBD by creating more potent derivatives that can be absorbed by the body.

SourceAmerican Chemical Society·JournalChemical & Engineering News·DateSep 2, 2020

Drug reduces the risk of child sexual abuse

A new drug called degarelix, approved for prostate cancer treatment, has been shown to reduce the risk of men with pedophilic disorder committing child sexual abuse. The drug, administered every three months, dampens critical risk factors such as high sexual desire and attraction to children.

SourceKarolinska Institutet·JournalJAMA Psychiatry·DateApr 29, 2020

Gaps remain in rural opioid crisis research

A new study by Rutgers University and colleagues highlights the need for more research on rural opioid crisis treatment, citing barriers to access and inadequate resources. The researchers recommend expanded telemedicine, low-cost technology-assisted treatment, transportation subsidies, and pharmacy legislation changes.

SourceRutgers University·JournalThe American Journal of Drug and Alcohol Abuse·DateFeb 6, 2020

Natural herb kratom may have therapeutic effects and relatively low potential for abuse or harm, according to a user survey

A survey of over 2,700 kratom users found the substance has a lower rate of harm than prescription opioids for treating pain, anxiety, and depression. While self-reporting surveys are not always reliable, the results suggest kratom may have medical applications to explore as an alternative to opioid use.

SourceJohns Hopkins Medicine·JournalDrug and Alcohol Dependence·DateFeb 3, 2020

Siri, help me quit -- what does your smart device say when you ask for help with addiction?

A recent study found that leading smart device conversational agents, such as Siri and Alexa, are unable to provide meaningful help for quitting substances like opioids, alcohol, and tobacco. However, researchers suggest that updating these devices to promote resources like helplines could prove highly effective in addressing the natio...

SourceElevated Science Communications·Journalnpj Digital Medicine·DateJan 29, 2020

Opioid dependence found to permanently change brains of rats

Researchers found that opioid dependence leads to permanent neuro-adaptations in the central nucleus of the amygdala, affecting pain transmission and GABA receptor activation. Normalizing nociceptin levels resulted in reduced opioid consumption, suggesting the peptide as a promising target for opioid use disorder treatment.

SourceUniversity of California - San Diego·JournalProceedings of the National Academy of Sciences·DateJan 24, 2020

Pharmacies leave customers hanging when it comes to disposing of antibiotics and opioids

A study by researchers at UC San Francisco found that fewer than half of California pharmacies provided correct disposal instructions for antibiotics and opioids. Only 10% followed the FDA's recommended takeback programs. Improving disposal practices requires better education and expanded programs to ensure patient safety.

SourceUniversity of California - San Francisco·JournalAnnals of Internal Medicine·DateDec 30, 2019

Teen overdoses from anxiety drug rising

A national study found a significant rise in teens taking and overdosing on benzodiazepines, commonly prescribed anxiety medications. The rate of exposure among adolescents increased by 54% between 2000 and 2015, with nearly half of all reported exposures documented as intentional abuse or misuse.

SourceRutgers University·JournalClinical Toxicology·DateDec 17, 2019

Problem drinkers have higher 'benzo' use, UCSF-Kaiser Permanente study shows

Researchers at UCSF-Kaiser Permanente found that primary care patients with 'unhealthy alcohol use' were 15% more likely to take benzodiazepines than moderate drinkers and nondrinkers. This increased risk was associated with a higher likelihood of overdose, accidents, falls, and exacerbation of psychiatric conditions.

SourceUniversity of California - San Francisco·JournalThe American Journal of Managed Care·DateDec 13, 2019

MA physician assistant programs adopt first-in-nation partnership to prevent opioid abuse

In an effort to curb opioid misuse, Massachusetts physician assistant programs have adopted a cross-institutional partnership to ensure safe prescribing practices. The initiative aims to educate students on the prevention and management of prescription drug misuse, following a consensus-building process among nine PA programs.

SourceBoston University School of Medicine·JournalThe Journal of Physician Assistant Education·DateDec 3, 2019

Chronic opioid treatment may raise risk of post-traumatic stress disorder, study finds

A new UCLA-led study suggests chronic opioid treatment may raise the risk of post-traumatic stress disorder (PTSD) in individuals who are likely to experience severe emotional stress. Researchers found that mice given morphine before and after a traumatic event showed enhanced fear learning, indicating increased PTSD susceptibility.

SourceUniversity of California - Los Angeles·JournalNeuropsychopharmacology·DateDec 3, 2019